MLAB
Mesa Laboratories, Inc.Healthcare · $743M market cap
Verdict
Share price
$132.55
close of Oct 3, 2026
Fair value
$137.16
Sticker Price
Payback Price
$54.86
buy price
MLAB is Fairly Valued: at $132.55 it's within 3% of its fair value of $137.16. Its buy price (Payback Price) is $54.86, 59% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.
How we valued it
Free Cash Flow Growth. Free cash flow is growing faster than reported earnings, so we project free cash flow 10 years ahead instead.
Business quality
3 of 5 clear the 10% bar. What are the Big Five?
Follow MLAB
Get notified when it reaches its buy price of $54.86. Free.
Create a free accountInsider activity
Since Sep 9, 2009: 2 open-market purchases worth $902K, 7 sales worth $1.6M and 37 other filings (stock awards, tax withholding and similar). Why purchases matter
Purchases
Tripeny R Tony
director · 2026-08-13
Bought
$102K
Kadia Siddhartha
President and CEO · 2026-08-13
Bought
$800K
Sales
Sullivan John James
director · 2026-08-13
Sold
$800K
Sakys John
CFO · 2026-06-22
Sold
$253K
Archbold Brian David
SVP Operations · 2026-06-22
Sold
$225K
Crennen Lyndsey Elizabeth
CAO · 2026-06-22
Sold
$40K
Sakys John
CFO · 2026-06-16
Sold
$124K
Other filings
Tripeny R Tony
director · 2026-09-09
Award
1,774 shares
Sullivan John James
director · 2026-09-09
Award
1,774 shares
Hall Shannon
director · 2026-09-09
Award
1,774 shares
Ladiwala Shiraz Shabanali
director · 2026-09-09
Award
2,510 shares
Capone Mark Christopher
director · 2026-09-09
Award
2,423 shares
Show all 37 other filingsShow fewer
Sullivan John James
director · 2026-08-15
Option exercise
2,784 shares
Tripeny R Tony
director · 2026-08-15
Option exercise
2,784 shares
Hall Shannon
director · 2026-08-15
Option exercise
2,784 shares
Ladiwala Shiraz Shabanali
director · 2026-08-15
Option exercise
3,810 shares
Alltoft Jennifer Sadie
director · 2026-08-15
Option exercise
2,784 shares
Capone Mark Christopher
director · 2026-08-15
Option exercise
2,784 shares
Sakys John
CFO · 2026-06-18
Option exercise
1,036 shares
Sakys John
CFO · 2026-06-18
Option exercise
2,756 shares
Sakys John
CFO · 2026-06-18
Option exercise
$99K
Sakys John
CFO · 2026-06-18
Option exercise
$262K
Sakys John
CFO · 2026-06-18
Award
$217K
Archbold Brian David
SVP Operations · 2026-06-18
Option exercise
844 shares
Archbold Brian David
SVP Operations · 2026-06-18
Option exercise
2,480 shares
Archbold Brian David
SVP Operations · 2026-06-18
Option exercise
$80K
Archbold Brian David
SVP Operations · 2026-06-18
Option exercise
$236K
Archbold Brian David
SVP Operations · 2026-06-18
Award
$177K
Crennen Lyndsey Elizabeth
CAO · 2026-06-18
Option exercise
125 shares
Crennen Lyndsey Elizabeth
CAO · 2026-06-18
Option exercise
233 shares
Crennen Lyndsey Elizabeth
CAO · 2026-06-18
Option exercise
368 shares
Crennen Lyndsey Elizabeth
CAO · 2026-06-18
Option exercise
$12K
Crennen Lyndsey Elizabeth
CAO · 2026-06-18
Option exercise
$22K
Crennen Lyndsey Elizabeth
CAO · 2026-06-18
Option exercise
$35K
Crennen Lyndsey Elizabeth
CAO · 2026-06-18
Award
$25K
Sakys John
CFO · 2026-06-15
Option exercise
2,717 shares
Sakys John
CFO · 2026-06-15
Award
8,416 shares
Sakys John
CFO · 2026-06-15
E-ExpireShort
$896K
Sakys John
CFO · 2026-06-15
Option exercise
$283K
Archbold Brian David
SVP Operations · 2026-06-15
Award
4,328 shares
Archbold Brian David
SVP Operations · 2026-06-15
Option exercise
$255K
Archbold Brian David
SVP Operations · 2026-06-15
Option exercise
2,454 shares
Archbold Brian David
SVP Operations · 2026-06-15
E-ExpireShort
$404K
Alltoft Jennifer Sadie
director · 2009-09-09
Award
1,774 shares
About Mesa Laboratories, Inc.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the…
Medical - Specialties
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works